Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Return on Sales: 2011-2025

Historic Return on Sales for Arrowhead Pharmaceuticals (ARWR) over the last 14 years, with Sep 2025 value amounting to 0.04%.

  • Arrowhead Pharmaceuticals' Return on Sales fell 2598.00% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 2598.00%. This contributed to the annual value of 0.04% for FY2025, which is 17173.00% up from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Return on Sales of 0.04% as of Q3 2025, which was up 112.70% from -0.29% recorded in Q2 2025.
  • Arrowhead Pharmaceuticals' 5-year Return on Sales high stood at 26.53% for Q4 2024, and its period low was -74.87% during Q2 2024.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Return on Sales value was -0.56% (recorded in 2023), while the average stood at -3.96%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by 7,415bps in 2024, then skyrocketed by 7,459bps in 2025.
  • Quarterly analysis of 5 years shows Arrowhead Pharmaceuticals' Return on Sales stood at -1.27% in 2021, then soared by 71bps to -0.56% in 2022, then slumped by 111bps to -1.67% in 2023, then skyrocketed by 2,819bps to 26.53% in 2024, then crashed by 2,598bps to 0.04% in 2025.
  • Its last three reported values are 0.04% in Q3 2025, -0.29% for Q2 2025, and -0.29% during Q1 2025.